Revision of Organization and Conforming Changes to Regulations, 16353-16357 [2010-7282]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Rules and Regulations
16353
such information is required for
purposes of section 535 of the Act; and
*
*
*
*
*
PART 1010—PERFORMANCE
STANDARDS FOR ELECTRONIC
PRODUCTS: GENERAL
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
4. Section 1002.42 is revised to read
as follows:
■
9. The authority citation for 21 CFR
part 1010 is revised to read as follows:
21 CFR Chapter I
§ 1002.42 Confidentiality of records
furnished by dealers and distributors.
Authority: 21 U.S.C. 351, 352, 360, 360e–
360j, 360hh–360ss, 371, 381.
[Docket No. FDA–2010–N–0148]
All information furnished to
manufacturers by dealers and
distributors pursuant to this part shall
be treated by such manufacturers as
confidential information which may be
used only as necessary to notify persons
pursuant to section 535 of the Act.
■
10. In 1010.4, paragraph (c)(3) is
revised to read as follows:
Revision of Organization and
Conforming Changes to Regulations
■
PART 1003—NOTIFICATION OF
DEFECTS OR FAILURE TO COMPLY
5. The authority citation for 21 CFR
part 1003 is revised to read as follows:
■
Authority: 21 U.S.C. 360hh–360ss.
PART 1004—REPURCHASE, REPAIRS,
OR REPLACEMENT OF ELECTRONIC
PRODUCTS
6. The authority citation for 21 CFR
part 1004 is revised to read as follows:
§ 1010.4
Variances.
AGENCY:
*
*
*
*
*
(c) * * *
(3) All applications for variances and
for amendments and extensions thereof
and all correspondence (including
written notices of approval) on these
applications will be available for public
disclosure in the office of the Division
of Dockets Management, except for
information regarded as confidential
under section 537(e) of the act.
*
*
*
*
*
PART 1020—PERFORMANCE
STANDARDS FOR IONIZING
RADIATION EMITTING PRODUCTS
■
Authority: 21 U.S.C. 360hh–360ss.
7. The authority citation for 21 CFR
part 1005 is revised to read as follows:
■
Authority: 21 U.S.C. 360ii, 360mm.
8. In 1005.25, paragraph (c) is revised
to read as follows:
■
emcdonald on DSK2BSOYB1PROD with RULES
*
*
*
*
(c) Service of any process, notice,
order, requirement, or decision
specified in section 536(d) of
Subchapter C—Electronic Product
Radiation Control of the Federal Food,
Drug, and Cosmetic Act (formerly the
Radiation Control for Health and Safety
Act of 1968) (21 U.S.C. 360mm(d)) may
be made by registered or certified mail
addressed to the agent with return
receipt requested, or in any other
manner authorized by law. In the
absence of such a designation or if for
any reason service on the designated
agent cannot be effected, service may be
made as provided in section 536(d) by
posting such process, notice, order,
requirement, or decision in the Office of
the Director, Center for Devices and
Radiological Health and publishing a
notice that such service was made in the
Federal Register.
VerDate Nov<24>2008
15:00 Mar 31, 2010
Jkt 220001
PART 1030—PERFORMANCE
STANDARDS FOR MICROWAVE AND
RADIO FREQUENCY EMITTING
PRODUCTS
12. The authority citation for 21 CFR
part 1030 is revised to read as follows:
■
Authority: 21 U.S.C. 351, 352, 360, 360e–
360j, 360hh–360ss, 371, 381.
§ 1005.25 Service of process on
manufacturers.
*
11. The authority citation for 21 CFR
part 1020 is revised to read as follows:
■
Authority: 21 U.S.C. 351, 352, 360e–360j,
360hh–360ss, 371, 381.
PART 1005—IMPORTATION OF
ELECTRONIC PRODUCTS
PART 1040—PERFORMANCE
STANDARDS FOR LIGHT-EMITTING
PRODUCTS
13. The authority citation for 21 CFR
part 1040 is revised to read as follows:
■
Authority: 21 U.S.C. 351, 352, 360, 360e–
360j, 360hh–360ss, 371, 381.
PART 1050—PERFORMANCE
STANDARDS FOR SONIC,
INFRASONIC, AND ULTRASONIC
RADIATION-EMITTING PRODUCTS
14. The authority citation for 21 CFR
part 1050 is revised to read as follows:
■
Authority: 21 U.S.C. 351, 352, 360, 360e–
360j, 360hh–360ss, 371, 381.
Dated: March 29, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–7288 Filed 3–31–10; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00029
Fmt 4700
Food and Drug Administration
Sfmt 4700
Food and Drug Administration,
HHS.
ACTION:
Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is issuing this
final rule to amend the regulations to
reflect organization change in the
agency and to make other conforming
changes. This action is editorial in
nature and is intended to improve the
accuracy of the agency’s regulations.
DATES: This rule is effective April 1,
2010.
FOR FURTHER INFORMATION CONTACT:
Vanessa Starks, Office of Management
Programs (HFA–410), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–4654; or
Sharon Burgess, Division of Human
Capital Management (HFA–410), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
2065.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is issuing this final rule to
amend its regulations by updating the
organizational information in part 5 (21
CFR part 5).
The agency has updated the
references to part 5, subpart M.
The portion of this final rule updating
the organizational information in part 5,
subpart M is a rule of agency
organization, procedure, or practice.
FDA is issuing these provisions as a
final rule without publishing a general
notice of proposed rulemaking because
such notice is not required for rules of
agency organization, procedure, or
practice under 5 U.S.C. 553(b)(3)(A). For
the conforming changes to the other
regulations, the agency finds good cause
under 5 U.S.C. 553(b)(3)(B) to dispense
with prior notice and comment, and
good cause under 5 U.S.C. 553(d)(3) to
make these conforming changes
effective less than 30 days after
publication because such notice and
comment and delayed effective date are
unnecessary and contrary to the public
interest. These conforming changes
merely update the footnotes in part 5,
subpart M. These changes do not result
E:\FR\FM\01APR1.SGM
01APR1
16354
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Rules and Regulations
in any substantive change in the
regulations.
List of Subjects in 21 CFR Part 5
Authority delegations (Government
agencies), Imports, Organization and
functions (Government agencies).
■ Therefore, under the Federal Food,
Drug, and Cosmetic Act and under the
authority of the Commissioner of Food
and Drugs, 21 CFR Part 5 is amended as
follows:
■ 1. Part 5 is revised to read as follows:
PART 5—ORGANIZATION
Subparts A–L—[Reserved]
Subpart M—Organization
Sec.
5.1100 Headquarters.
5.1105 Chief Counsel, Food and Drug
Administration.
5.1110 FDA Public Information Offices.
Authority: 5 U.S.C. 552; 21 U.S.C. 301–
397.
Subparts A–L—[Reserved]
Subpart M—Organization
§ 5.1100
Headquarters.
emcdonald on DSK2BSOYB1PROD with RULES
The central organization of the Food
and Drug Administration consists of the
following:
OFFICE OF THE COMMISSIONER.1
Office of the Chief Counsel.2
Office of the Administrative Law Judge.1
Office of Women’s Health.
Office of Policy, Planning & Budget.1
Office of Policy.
Policy Development and Coordination
Staff.
Regulations Policy and Management
Staff.
Regulations Editorial Section.
Office of Planning.1
Planning Staff.
Evaluation Staff.
Economics Staff.
Risk Communication Staff.
Business Process Planning Staff.
Office of Budget.1
Office of Legislation.3
Office of the Counselor to the
Commissioner.1
1 Mailing address: 10903 New Hampshire Ave.,
Silver Spring, MD 20906.
2 The Office of the Chief Counsel (also known as
the Food and Drug Division, Office of the General
Counsel, Department of Health and Human
Services), while administratively within the Office
of the Commissioner, is part of the Office of the
General Counsel of the Department of Health and
Human Services.
3 Mailing address: 5600 Fishers Lane, Rockville,
MD 20857.
VerDate Nov<24>2008
15:00 Mar 31, 2010
Jkt 220001
Division of Travel Services.
Office of Information Management.6
Division of Business Partnership and
Support.6
Division of Chief Information Officer
Support.6
Division of Systems Management.7
Division of Infrastructure Operations.8
Division of Technology.8
Office of Management.3
Ethics and Integrity Staff.
Office of Business Operations and
Human Capital Programs.
Office of Management Programs.
Office of Security Operations.
Office of White Oak Services.1
Division of Logistics Services and
Facilities Operations.
Division of White Oak Consolidation.
Office of Shared Services.5
Office of Real Property Services.
Jefferson Laboratories Complex Staff.
Division of Engineering Services.
Environment, Safety And Strategic
Initiatives Staff.
Division of Facilities Operations.
Portfolio Development Staff.
Employee Resource & Information
Center.
Office of Public Information and Library
Services.
Division of Dockets Management.
Division of Freedom of Information.
FDA Biosciences Library.
Public Services Branch.
Technical Services Branch.
Office of Crisis Management.
Office of Emergency Operations.
Office of the Chief Of Staff.1
Executive Secretariat.
Office of Special Medical Programs.
Office of Good Clinical Practice.
Office of Combination Products.4
Office of Orphan Products
Development.
Office of Pediatric Therapeutics.3
Office of International Programs.3
Office of External Affairs.
Office of External Relations.3
Communications Staff.
Office of Public Affairs.1
Web Communications Staff.
Office of Special Health Issues.3
Medwatch Staff.
Office of Foods.1
Office of the Chief Scientist.1
Office of Counter-Terrorism and
Emerging Threats.3
Office of Critical Path Programs.
Office of Scientific Integrity.
Office of Science and Innovation.
Office of International Programs.3
Office of Administration.1
Office of Equal Employment
Opportunity & Diversity Management.3
Conflict Prevention and Resolution
Staff.
Compliance Staff.
Diversity Staff.
Office of Acquisitions and Grants
Services.5
Division of Acquisition Operations.
Division of Acquisition Support and
Grants.
Division of Acquisition Programs.
Division of Information Technology.
Office of Executive Operations.1
Office of Financial Operations.6
Office of Financial Management.6
Controls, Compliance, and Oversight
Staff.
Business Transformation,
Administration and Management Staff.
User Fees Staff.
Financial Systems Support Staff.
Division of Accounting.
Division of Budget Execution and
Control.
Office of Financial Services.
Division of Payment Services.
FDA History Office.
CENTER FOR BIOLOGICS
EVALUATION AND RESEARCH.9
Office of the Center Director.
Regulations Policy Staff.
Quality Assurance Staff.
Office of Management.
Regulatory Information Management
Staff.
Division of Planning, Evaluation, and
Budget.
Division of Veterinary Services.
Division of Program Services.
Division of Scientific Advisors &
Consultants.
Building Operations Staff.
Office of Compliance and Biologics
Quality.
4 Mailing address: 15800 Crabbs Branch Way,
Rockville, MD 20855.
5 Mailing address: 5630 Fishers Lane, Rockville,
MD 20857.
6 Mailing address: 1350 Piccard Dr., Rockville,
MD 20850.
7 Mailing address: 2094 Gaither Rd., Rockville,
MD 20850.
8 Mailing address: 2098 Gaither Rd., Rockville,
MD 20850.
9 Mailing address: 1401 Rockville Pike, Rockville,
MD 20852.
PO 00000
Frm 00030
Fmt 4700
Sfmt 4700
E:\FR\FM\01APR1.SGM
01APR1
emcdonald on DSK2BSOYB1PROD with RULES
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Rules and Regulations
Division of Case Management.
Division of Inspections and
Surveillance.
Division of Manufacturing and Product
Quality.
Office of Biostatistics and Epidemiology.
Division of Biostatistics.
Division of Epidemiology.
Office of Information Management.
Division of Information Operations.
Division of Information Development.
Office of Blood Research and Review.
Policy and Publications Staff.
Division of Emerging and Transfusion
Transmitted Diseases.
Division of Hematology.
Division of Blood Applications.
Office of Vaccines Research and Review.
Program Operation Staff.
Division of Product Quality.
Division of Bacterial, Parasitic, and
Allergenic Products.
Division of Viral Products.
Division of Vaccines and Related
Product Applications.
Office of Cellular, Tissue, and Gene
Therapies.
Regulatory Management Staff.
Division of Cellular and Gene
Therapies.
Division of Clinical Evaluation and
Pharmacology/Toxicology.
Division of Human Tissues.
Office of Communication, Outreach and
Development.
Division of Disclosure and Oversight
Management.
Division of Manufacturers Assistance
and Training.
Division of Communication and
Consumer Affairs.
CENTER FOR DEVICES AND
RADIOLOGICAL HEALTH.1
Office of the Center Director.
Office of Systems and Management.
Division of Ethics and Management
Operations.
Division of Planning, Analysis and
Finance.
Division of Information Dissemination.
Division of Information Technology.
Office of Compliance.
Promotion and Advertising Policy Staff.
Division of Bioresearch Monitoring.
Division of Program Operations.
Division of Enforcement A.
Division of Enforcement B.
Office of Device Evaluation.
Program Management Staff.
Program Operations Staff.
VerDate Nov<24>2008
15:00 Mar 31, 2010
Jkt 220001
16355
Division of Cardiovascular Devices.
Division of Reproductive, Gastro-Renal
and Urological Devices.
Division of General, Restorative, and
Neurological Devices.
Division of Surgical, Orthopedic and
Restorative Devices.
Division of Ophthalmic, and Ear, Nose
and Throat Devices.
Division of Anesthesiology, General
Hospital, Infection Control, and Dental
Devices.
Office of Science and Engineering
Laboratories.
Division of Biology.
Management Support Staff.
Standards Management Staff.
Division of Chemistry and Materials
Science.
Division of Solid and Fluid Mechanics.
Division of Physics.
Division of Imaging and Applied
Mathematics.
Office of Communication, Education
and Radiation Programs.
Program Operations Staff.
Regulations Staff.
Staff College.
Division of Device User Programs and
Systems Analysis.
Division of Small Manufacturers
Assistance.
Division of Mammography Quality and
Radiation Programs.
Division of Communication Media.
Office of Surveillance and Biometrics.
Issues Management Staff.
Division of Biostatistics.
Division of Postmarket Surveillance.
Division of Surveillance Systems.
Office of In Vitro Diagnostic Device
Evaluation and Safety.
Division of Chemistry and Toxicology
Devices.
Division of Immunology and
Hematology Devices.
Division of Microbiology Devices.
Division of Radiological Devices.
CENTER FOR DRUG EVALUATION
AND RESEARCH.10
Office of the Center Director.
Controlled Substance Staff.
Office of Regulatory Policy.
Division of Regulatory Policy I.
Division of Regulatory Policy II.
Division of Regulatory Policy III.
Division of Information Disclosure
Policy.
Office of Management.
Division of Management and Budget.
Division of Management Services.
Office of Communications.
Division of Information Services.
Division of Public Affairs.
Division of Drug Information.
Office of Surveillance and
Epidemiology.11
Review and Management Staff.
Business Process Improvement Staff.
Regulatory Policy Staff.
Division of Medication Error Prevention
and Analysis.
Division of Pharmacovigilance I.
Division of Pharmacovigilance II.
Division of Drug Risk Evaluation.
Division of Epidemiology.
Office of Compliance.1
Division of Compliance Risk
Management and Surveillance.
Division of New Drugs and Labeling
Compliance.
Division of Manufacturing and Product
Quality.
Division of Scientific Investigations.
Office of New Drugs.2
Pediatric and Maternal Health Staff.
Program Management Analysis Staff.
Office of Drug Evaluation I.
Division of Cardiorenal Cardiovascular
and Renal Drug Products.
Division of Neurology Products.
Division of Psychiatry Products.
Office of Drug Evaluation II.
Division of Metabolism and
Endocrinology Products.
Division of Pulmonary, Allergy and
Rheumatology Products.
Division of Anesthesia and Analgesia
Products.
Office of Drug Evaluation III.
Division of Gastroenterology Products.
Division of Reproductive and Urologic
Products.
Division of Dermatology and Dental
Products.
Office of Antimicrobial Products.
Division of Anti-Infective and
Ophthalmology Products.
Division of Anti-Viral Products.
Division of Special Pathogen and
Transplant Products.
Office of Drug Evaluation IV.
Division of Nonprescription Clinical
Evaluation.
Division of Nonprescription Regulation
Development.
10 Mailing address: 10903 New Hampshire Ave.,
White Oak Bldg. 51, Silver Spring, MD 20993.
11 Mailing address: 10903 New Hampshire Ave.,
White Oak Bldg. 22, Silver Spring, MD 20993.
PO 00000
Frm 00031
Fmt 4700
Sfmt 4700
E:\FR\FM\01APR1.SGM
01APR1
emcdonald on DSK2BSOYB1PROD with RULES
16356
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Rules and Regulations
Division of Medical Imaging Products.
Office of Oncology Drug Products.
Division of Drug Oncology Products.
Division of Hematology Products.
Division of Biologic Oncology Products.
Office of Pharmaceutical Science.1
Program Activities Review Staff.
Operations Staff.
Science and Research Staff
New Drug Microbiology Staff.
Office of Generic Drugs.12
Division of Bioequivalence.
Division of Labeling and Program
Support.
Division of Chemistry I.
Division of Chemistry II.
Division of Chemistry III.
Office of New Drug Quality
Assessment.13
Division of New Drug Quality
Assessment I.
Division of New Drug Quality
Assessment II.
Branch IV.
Branch V.
Branch VI.
Division of New Drug Quality
Assessment III.
Branch VII.
Branch VIII.
Branch IX.
Office of Testing and Research.2
Laboratory of Clinical Pharmacology.
Division of Applied Pharmacology
Research.
Division of Pharmaceutical Analysis.
Division of Product Quality Research.
Office of Biotechnology Products.4
Division of Monoclonal Antibodies.
Division of Therapeutic Protein.
Office of Medical Policy.2
Division of Drug Marketing, Advertising
and Communication.
Office of Executive Programs.1
Division of Training and Development.
Division of Executive Operations.
Division of Advisory Committee and
Consultant Management.
Office of Translational Sciences.4
Office of Biostatistics.
Division of Biometrics I.
Division of Biometrics II.
Division of Biometrics III.
Division of Biometrics IV.
Division of Biometrics V.
12 Mailing address: 7519 Standish Pl., Bldg.
MPN4, Rockville, MD 20855.
13 Mailing address: 10903 New Hampshire Ave.,
White Oak Bldg. 21, Silver Spring, MD 20993.
VerDate Nov<24>2008
15:00 Mar 31, 2010
Jkt 220001
Division of Biometrics VI.
Division of Biometrics VII.
Office of Clinical Pharmacology.1
Division of Clinical Pharmacology I.
Division of Clinical Pharmacology II.
Division of Clinical Pharmacology III.
Division of Clinical Pharmacology IV.
Division of Clinical Pharmacology V.
Division of Pharmacometrics.
Office of Counter-Terrorism and
Emergency Coordinator.
Office of Planning and Informatics.
Office of Planning and Analysis.
Planning and Evaluation Staff.
Analysis Staff.
Office of Business Informatics.
Division of Records Management.
Division of Regulatory Review Support.
Division of Business Analysis and
Reporting.
Division of Project Development.
CENTER FOR FOOD SAFETY AND
APPLIED NUTRITION.14
Office of the Center Director.
Senior Science Advisor Staff.
Executive Operations Staff.
International Staff.
Office of Management Systems.
Division of Planning and Financial
Resources Management.
Division of Program Support Services.
Office of Food Defense, Communication
and Emergency Response.
Division of Education and
Communication.
Division of Public Health and
Biostatistics.
Office of Food Safety.
Retail Food and Cooperative Programs
Support Staff.
Division of Seafood Science and
Technology.
Division of Food Processing Science and
Technology.
Division of Plant and Dairy Food Safety.
Division of Seafood Safety.
Office of Cosmetics and Colors.
Cosmetic Staff.
Division of Color Certification and
Technology.
Office of Regulatory Science.
Division of Analytical Chemistry.
Division of Microbiology.
Division of Bioanalytical Chemistry.
Office of Food Additive Safety.
Senior Science and Policy Staff.
Division of Food Contact Notifications.
14 Mailing address: 5100 Paint Branch Pkwy.,
College Park, MD 20740–3835.
PO 00000
Frm 00032
Fmt 4700
Sfmt 4700
Division of Biotechnology and GRAS
Notice Review.
Office of Compliance.
Division of Enforcement.
Division of Field Programs and
Guidance.
Office of Applied Research and Safety
Assessment.
Muirkirk Technical Operations Staff.
Division of Molecular Biology.
Division of Virulence Assessment.
Division of Toxicology.
Office of Regulations, Policy and Social
Sciences.
Regulations and Special Government
Employees Management Staff.
Division of Social Sciences.
Office of Nutrition, Labeling and Dietary
Supplements.
Food Labeling and Standards Staff.
Nutrition Programs Staff.
Infant Formula and Medical Foods Staff.
Division of Dietary Supplement
Programs.
CENTER FOR TOBACCO PRODUCTS.15
Office of the Center Director.
Office of Management.
Office of Policy.
Office of Regulations.
Office of Science.
NATIONAL CENTER FOR
TOXICOLOGY RESEARCH.16
Office of the Center Director.
Office of Management.
Office of Executive Programs and
Services.
Office of Scientific Coordination.
Office of Research.
Division of Biochemical Toxicology.
Division of Genetic and Reproductive
Toxicology.
Genetic Toxicology Laboratory.
Reproductive Toxicology Laboratory.
Division of Personalized Nutrition and
Medicine.
Biometry Branch.
Pharmacogenomics Branch.
Division of Microbiology.
Division of Neurotoxicology.
Division of Veterinary Services.
Division of Systems Toxicology.
Office of Regulatory Compliance and
Risk Management.
OFFICE OF REGULATORY AFFAIRS.3
Equal Employment Opportunity Staff.
Office of Resource Management.3
15 Mailing address: 9200 Corporate Blvd.,
Rockville, MD 20850.
16 Mailing address: 3900 NCTR Rd., Jefferson, AR
72079.
E:\FR\FM\01APR1.SGM
01APR1
Federal Register / Vol. 75, No. 62 / Thursday, April 1, 2010 / Rules and Regulations
emcdonald on DSK2BSOYB1PROD with RULES
Division of Planning, Evaluation, and
Management.
Division of Human Resource
Development.
Division of Management Operations.
Division of Personnel Operations.
Office of Information Technology.
Office of Enforcement.5
Division of Compliance Management
and Operations.
Division of Compliance Policy.
Division of Compliance Information and
Quality Assurance.
Office of Regional Operations.3
Division of Federal-State Relations.
Division of Field Science.
Division of Import Operations and
Policy.
Division of Field Investigations.
Office of Criminal Investigations.17
Mid-Atlantic Area Office.3
Midwest Area Office.18
Northeast Area Office.19
Pacific Area Office.20
Southeast Area Office.21
Southwest Area Office.22
CENTER FOR VETERINARY
MEDICINE.23
Office of the Center Director.
Office of Management.24
Management Logistics Staff.
Financial Resources Staff.
Human Capital Staff.
Learning Management Staff.
Office of New Animal Drug
Evaluation.25
Division of Therapeutic Drugs for NonFood Animals.
Division of Biometrics and Production
Drugs.
Division of Therapeutic Drugs for Food
Animals.
Division of Human Food Safety.
Division of Manufacturing
Technologies.
Division of Scientific Support.
17 Mailing address: 7500 Standish Pl., Rockville,
MD 20855.
18 Mailing address: 901 Warrenville Rd., Lisle, IL
60532.
19 Mailing address: 10 Exchange Pl., Jersey City,
NJ 07302.
20 Mailing address: 201 Avenida Fabricante, San
Clemente, CA 92672.
21 Mailing address: 865 SW 78th Ave., Plantation,
FL 33324.
22 Mailing address: 5799 Broadmoor St., Mission,
KS 66202.
23 Mailing address: 7519 Standish Pl., Bldg.
MPN4, rm. 176, Rockville, MD 20855.
24 Mailing address: 7529 Standish Pl., Bldg.
MPN5, rm. 3577, Rockville, MD 20855.
25 Mailing address: 7520 Standish Pl., Bldg.
MPN2, rm. 239, Rockville, MD 20855.
VerDate Nov<24>2008
15:00 Mar 31, 2010
Jkt 220001
16357
Division of Generic Animal Drugs.
DEPARTMENT OF TRANSPORTATION
Office of Surveillance and
Compliance.26
Office of the Secretary
Division of Surveillance.
49 CFR Part 23
Division of Animal Feeds.
[Docket No. OST–2010–0022]
Division of Compliance.
RIN 2105–AD88
Division of Epidemiology.
Participation by Disadvantaged
Business Enterprises in Airport
Concessions
Office of
Research.27
Administrative Staff
AGENCY:
Division of Residue Chemistry.
DOT.
ACTION:
Division of Animal Research.
Division of Animal and Food
Microbiology.
Office of Minor Use and Minor Species
Animal Drug Development.28
§ 5.1105 Chief Counsel, Food and Drug
Administration.
The Office of the Chief Counsel’s
mailing address is 5600 Fishers Lane,
rm. 6–05, Rockville, MD 20857.1
§ 5.1110
FDA public information offices.
(a) Division of Dockets Management.
The Division of Dockets Management
public room is located in rm. 1061, 5630
Fishers Lane, Rockville, MD 20852,
Telephone: 301–827–6860.
(b) Division of Freedom of
Information. The Freedom of
Information public room is located in
rm. 6–30, Parklawn Bldg., 5600 Fishers
Lane, Rockville, MD 20857, Telephone:
301–827–6567.
(c) Press Relations Staff. Press offices
are located in White Oak Bldg. 1, 10903
New Hampshire Ave., Silver Spring, MD
20993, Telephone: 301–827–6242; and
at 5100 Paint Branch Pkwy., College
Park, MD 20740, Telephone: 301–436–
2335.
Dated: March 26, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–7282 Filed 3–31–10; 8:45 am]
BILLING CODE 4160–01–S
26 Mailing Address: 7519 Standish Pl., Bldg.
MPN5, rm. 300, Rockville, MD 20855.
27 Mailing address: 8401 Muirkirk Rd., Bldg.
MOD2, rm. G101, Laurel, MD 20708.
28 Mailing address: 7500 Standish Pl., Bldg.
MPN2, rm. N378, Rockville, MD 20855.
1 The Office of the Chief Counsel (also known as
the Food and Drug Division, Office of the General
Counsel, Department of Health and Human
Services), while administratively within the Office
of the Commissioner, is part of the Office of the
General Counsel of the Department of Health and
Human Services.
PO 00000
Frm 00033
Fmt 4700
Sfmt 4700
Office of the Secretary (OST),
Final rule.
SUMMARY: The Department of
Transportation is removing the ‘‘sunset’’
provision from its rule governing the
airport concessions disadvantaged
business enterprise (ACDBE) program.
The revised rule instead provides
reviewing the program to ensure that it
is being effectively implemented.
DATES: This rule is effective April 1,
2010.
FOR FURTHER INFORMATION CONTACT:
Robert C. Ashby, Deputy Assistant
General Counsel for Regulation and
Enforcement, U.S. Department of
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590,
Room W94–302, 202–366–9310,
bob.ashby@dot.gov.
SUPPLEMENTARY INFORMATION: When the
Department issued its final rule revising
its ACDBE rule (49 CFR part 23) in
2005, the rule included at section 23.7
a ‘‘sunset’’ provision. This provision
said, unless extended by the
Department, the provisions of part 23
would terminate and become
inoperative on April 21, 2010. The
preamble to the rule explained the
rationale for this provision as follows:
The Department is introducing a ‘‘sunset’’
provision into the final rule as a way of
addressing the durational element of narrow
tailoring. A narrowly-tailored rule is not
intended to remain in effect indefinitely.
Rather, the rule should be reviewed
periodically to ensure that it continues to be
needed and that it remains a constitutionally
appropriate way of implementing its
objectives. Consequently, this provision
states that this rule will terminate and cease
being operative in five years, unless the
Department extends it. We intend, beginning
four years from now, to review the rule to
determine whether it should be extended,
modified, or allowed to expire. Of course, the
underlying DBE statute remains in place, and
its requirements continue to apply regardless
of the status of this regulation, absent future
Congressional action. (70 FR 14502; March
22, 2005).
The Department believes that it is useful
to begin reviewing the provisions of part
23 at this time, for the purpose of
E:\FR\FM\01APR1.SGM
01APR1
]]>Agencies
[Federal Register Volume 75, Number 62 (Thursday, April 1, 2010)]
[Rules and Regulations]
[Pages 16353-16357]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7282]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Chapter I
[Docket No. FDA-2010-N-0148]
Revision of Organization and Conforming Changes to Regulations
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is issuing this final
rule to amend the regulations to reflect organization change in the
agency and to make other conforming changes. This action is editorial
in nature and is intended to improve the accuracy of the agency's
regulations.
DATES: This rule is effective April 1, 2010.
FOR FURTHER INFORMATION CONTACT: Vanessa Starks, Office of Management
Programs (HFA-410), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-4654; or Sharon Burgess, Division of Human
Capital Management (HFA-410), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-2065.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is issuing this final rule to amend its regulations by updating
the organizational information in part 5 (21 CFR part 5).
The agency has updated the references to part 5, subpart M.
The portion of this final rule updating the organizational
information in part 5, subpart M is a rule of agency organization,
procedure, or practice. FDA is issuing these provisions as a final rule
without publishing a general notice of proposed rulemaking because such
notice is not required for rules of agency organization, procedure, or
practice under 5 U.S.C. 553(b)(3)(A). For the conforming changes to the
other regulations, the agency finds good cause under 5 U.S.C.
553(b)(3)(B) to dispense with prior notice and comment, and good cause
under 5 U.S.C. 553(d)(3) to make these conforming changes effective
less than 30 days after publication because such notice and comment and
delayed effective date are unnecessary and contrary to the public
interest. These conforming changes merely update the footnotes in part
5, subpart M. These changes do not result
[[Page 16354]]
in any substantive change in the regulations.
List of Subjects in 21 CFR Part 5
Authority delegations (Government agencies), Imports, Organization
and functions (Government agencies).
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the
authority of the Commissioner of Food and Drugs, 21 CFR Part 5 is
amended as follows:
0
1. Part 5 is revised to read as follows:
PART 5--ORGANIZATION
Subparts A-L--[Reserved]
Subpart M--Organization
Sec.
5.1100 Headquarters.
5.1105 Chief Counsel, Food and Drug Administration.
5.1110 FDA Public Information Offices.
Authority: 5 U.S.C. 552; 21 U.S.C. 301-397.
Subparts A-L--[Reserved]
Subpart M--Organization
Sec. 5.1100 Headquarters.
The central organization of the Food and Drug Administration
consists of the following:
OFFICE OF THE COMMISSIONER.\1\
---------------------------------------------------------------------------
\1\ Mailing address: 10903 New Hampshire Ave., Silver Spring, MD
20906.
Office of the Chief Counsel.\2\
---------------------------------------------------------------------------
\2\ The Office of the Chief Counsel (also known as the Food and
Drug Division, Office of the General Counsel, Department of Health
and Human Services), while administratively within the Office of the
Commissioner, is part of the Office of the General Counsel of the
Department of Health and Human Services.
---------------------------------------------------------------------------
Office of the Administrative Law Judge.\1\
Office of Women's Health.
Office of Policy, Planning & Budget.\1\
Office of Policy.
Policy Development and Coordination Staff.
Regulations Policy and Management Staff.
Regulations Editorial Section.
Office of Planning.\1\
Planning Staff.
Evaluation Staff.
Economics Staff.
Risk Communication Staff.
Business Process Planning Staff.
Office of Budget.\1\
Office of Legislation.\3\
---------------------------------------------------------------------------
\3\ Mailing address: 5600 Fishers Lane, Rockville, MD 20857.
---------------------------------------------------------------------------
Office of the Counselor to the Commissioner.\1\
Office of Crisis Management.
Office of Emergency Operations.
Office of the Chief Of Staff.\1\
Executive Secretariat.
Office of Special Medical Programs.
Office of Good Clinical Practice.
Office of Combination Products.\4\
---------------------------------------------------------------------------
\4\ Mailing address: 15800 Crabbs Branch Way, Rockville, MD
20855.
---------------------------------------------------------------------------
Office of Orphan Products Development.
Office of Pediatric Therapeutics.\3\
Office of International Programs.\3\
Office of External Affairs.
Office of External Relations.\3\
Communications Staff.
Office of Public Affairs.\1\
Web Communications Staff.
Office of Special Health Issues.\3\
Medwatch Staff.
Office of Foods.\1\
Office of the Chief Scientist.\1\
Office of Counter-Terrorism and Emerging Threats.\3\
Office of Critical Path Programs.
Office of Scientific Integrity.
Office of Science and Innovation.
Office of International Programs.\3\
Office of Administration.\1\
Office of Equal Employment Opportunity & Diversity Management.\3\
Conflict Prevention and Resolution Staff.
Compliance Staff.
Diversity Staff.
Office of Acquisitions and Grants Services.\5\
---------------------------------------------------------------------------
\5\ Mailing address: 5630 Fishers Lane, Rockville, MD 20857.
---------------------------------------------------------------------------
Division of Acquisition Operations.
Division of Acquisition Support and Grants.
Division of Acquisition Programs.
Division of Information Technology.
Office of Executive Operations.\1\
Office of Financial Operations.\6\
---------------------------------------------------------------------------
\6\ Mailing address: 1350 Piccard Dr., Rockville, MD 20850.
---------------------------------------------------------------------------
Office of Financial Management.\6\
Controls, Compliance, and Oversight Staff.
Business Transformation, Administration and Management Staff.
User Fees Staff.
Financial Systems Support Staff.
Division of Accounting.
Division of Budget Execution and Control.
Office of Financial Services.
Division of Payment Services.
Division of Travel Services.
Office of Information Management.\6\
Division of Business Partnership and Support.\6\
Division of Chief Information Officer Support.\6\
Division of Systems Management.\7\
---------------------------------------------------------------------------
\7\ Mailing address: 2094 Gaither Rd., Rockville, MD 20850.
Division of Infrastructure Operations.\8\
---------------------------------------------------------------------------
\8\ Mailing address: 2098 Gaither Rd., Rockville, MD 20850.
---------------------------------------------------------------------------
Division of Technology.\8\
Office of Management.\3\
Ethics and Integrity Staff.
Office of Business Operations and Human Capital Programs.
Office of Management Programs.
Office of Security Operations.
Office of White Oak Services.\1\
Division of Logistics Services and Facilities Operations.
Division of White Oak Consolidation.
Office of Shared Services.\5\
Office of Real Property Services.
Jefferson Laboratories Complex Staff.
Division of Engineering Services.
Environment, Safety And Strategic Initiatives Staff.
Division of Facilities Operations.
Portfolio Development Staff.
Employee Resource & Information Center.
Office of Public Information and Library Services.
Division of Dockets Management.
Division of Freedom of Information.
FDA Biosciences Library.
Public Services Branch.
Technical Services Branch.
FDA History Office.
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH.\9\
---------------------------------------------------------------------------
\9\ Mailing address: 1401 Rockville Pike, Rockville, MD 20852.
---------------------------------------------------------------------------
Office of the Center Director.
Regulations Policy Staff.
Quality Assurance Staff.
Office of Management.
Regulatory Information Management Staff.
Division of Planning, Evaluation, and Budget.
Division of Veterinary Services.
Division of Program Services.
Division of Scientific Advisors & Consultants.
Building Operations Staff.
Office of Compliance and Biologics Quality.
[[Page 16355]]
Division of Case Management.
Division of Inspections and Surveillance.
Division of Manufacturing and Product Quality.
Office of Biostatistics and Epidemiology.
Division of Biostatistics.
Division of Epidemiology.
Office of Information Management.
Division of Information Operations.
Division of Information Development.
Office of Blood Research and Review.
Policy and Publications Staff.
Division of Emerging and Transfusion Transmitted Diseases.
Division of Hematology.
Division of Blood Applications.
Office of Vaccines Research and Review.
Program Operation Staff.
Division of Product Quality.
Division of Bacterial, Parasitic, and Allergenic Products.
Division of Viral Products.
Division of Vaccines and Related Product Applications.
Office of Cellular, Tissue, and Gene Therapies.
Regulatory Management Staff.
Division of Cellular and Gene Therapies.
Division of Clinical Evaluation and Pharmacology/Toxicology.
Division of Human Tissues.
Office of Communication, Outreach and Development.
Division of Disclosure and Oversight Management.
Division of Manufacturers Assistance and Training.
Division of Communication and Consumer Affairs.
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH.\1\
Office of the Center Director.
Office of Systems and Management.
Division of Ethics and Management Operations.
Division of Planning, Analysis and Finance.
Division of Information Dissemination.
Division of Information Technology.
Office of Compliance.
Promotion and Advertising Policy Staff.
Division of Bioresearch Monitoring.
Division of Program Operations.
Division of Enforcement A.
Division of Enforcement B.
Office of Device Evaluation.
Program Management Staff.
Program Operations Staff.
Division of Cardiovascular Devices.
Division of Reproductive, Gastro-Renal and Urological Devices.
Division of General, Restorative, and Neurological Devices.
Division of Surgical, Orthopedic and Restorative Devices.
Division of Ophthalmic, and Ear, Nose and Throat Devices.
Division of Anesthesiology, General Hospital, Infection Control, and
Dental Devices.
Office of Science and Engineering Laboratories.
Division of Biology.
Management Support Staff.
Standards Management Staff.
Division of Chemistry and Materials Science.
Division of Solid and Fluid Mechanics.
Division of Physics.
Division of Imaging and Applied Mathematics.
Office of Communication, Education and Radiation Programs.
Program Operations Staff.
Regulations Staff.
Staff College.
Division of Device User Programs and Systems Analysis.
Division of Small Manufacturers Assistance.
Division of Mammography Quality and Radiation Programs.
Division of Communication Media.
Office of Surveillance and Biometrics.
Issues Management Staff.
Division of Biostatistics.
Division of Postmarket Surveillance.
Division of Surveillance Systems.
Office of In Vitro Diagnostic Device Evaluation and Safety.
Division of Chemistry and Toxicology Devices.
Division of Immunology and Hematology Devices.
Division of Microbiology Devices.
Division of Radiological Devices.
CENTER FOR DRUG EVALUATION AND RESEARCH.\10\
---------------------------------------------------------------------------
\10\ Mailing address: 10903 New Hampshire Ave., White Oak Bldg.
51, Silver Spring, MD 20993.
---------------------------------------------------------------------------
Office of the Center Director.
Controlled Substance Staff.
Office of Regulatory Policy.
Division of Regulatory Policy I.
Division of Regulatory Policy II.
Division of Regulatory Policy III.
Division of Information Disclosure Policy.
Office of Management.
Division of Management and Budget.
Division of Management Services.
Office of Communications.
Division of Information Services.
Division of Public Affairs.
Division of Drug Information.
Office of Surveillance and Epidemiology.\11\
---------------------------------------------------------------------------
\11\ Mailing address: 10903 New Hampshire Ave., White Oak Bldg.
22, Silver Spring, MD 20993.
---------------------------------------------------------------------------
Review and Management Staff.
Business Process Improvement Staff.
Regulatory Policy Staff.
Division of Medication Error Prevention and Analysis.
Division of Pharmacovigilance I.
Division of Pharmacovigilance II.
Division of Drug Risk Evaluation.
Division of Epidemiology.
Office of Compliance.\1\
Division of Compliance Risk Management and Surveillance.
Division of New Drugs and Labeling Compliance.
Division of Manufacturing and Product Quality.
Division of Scientific Investigations.
Office of New Drugs.\2\
Pediatric and Maternal Health Staff.
Program Management Analysis Staff.
Office of Drug Evaluation I.
Division of Cardiorenal Cardiovascular and Renal Drug Products.
Division of Neurology Products.
Division of Psychiatry Products.
Office of Drug Evaluation II.
Division of Metabolism and Endocrinology Products.
Division of Pulmonary, Allergy and Rheumatology Products.
Division of Anesthesia and Analgesia Products.
Office of Drug Evaluation III.
Division of Gastroenterology Products.
Division of Reproductive and Urologic Products.
Division of Dermatology and Dental Products.
Office of Antimicrobial Products.
Division of Anti-Infective and Ophthalmology Products.
Division of Anti-Viral Products.
Division of Special Pathogen and Transplant Products.
Office of Drug Evaluation IV.
Division of Nonprescription Clinical Evaluation.
Division of Nonprescription Regulation Development.
[[Page 16356]]
Division of Medical Imaging Products.
Office of Oncology Drug Products.
Division of Drug Oncology Products.
Division of Hematology Products.
Division of Biologic Oncology Products.
Office of Pharmaceutical Science.\1\
Program Activities Review Staff.
Operations Staff.
Science and Research Staff
New Drug Microbiology Staff.
Office of Generic Drugs.\12\
---------------------------------------------------------------------------
\12\ Mailing address: 7519 Standish Pl., Bldg. MPN4, Rockville,
MD 20855.
---------------------------------------------------------------------------
Division of Bioequivalence.
Division of Labeling and Program Support.
Division of Chemistry I.
Division of Chemistry II.
Division of Chemistry III.
Office of New Drug Quality Assessment.\13\
---------------------------------------------------------------------------
\13\ Mailing address: 10903 New Hampshire Ave., White Oak Bldg.
21, Silver Spring, MD 20993.
---------------------------------------------------------------------------
Division of New Drug Quality Assessment I.
Division of New Drug Quality Assessment II.
Branch IV.
Branch V.
Branch VI.
Division of New Drug Quality Assessment III.
Branch VII.
Branch VIII.
Branch IX.
Office of Testing and Research.\2\
Laboratory of Clinical Pharmacology.
Division of Applied Pharmacology Research.
Division of Pharmaceutical Analysis.
Division of Product Quality Research.
Office of Biotechnology Products.\4\
Division of Monoclonal Antibodies.
Division of Therapeutic Protein.
Office of Medical Policy.\2\
Division of Drug Marketing, Advertising and Communication.
Office of Executive Programs.\1\
Division of Training and Development.
Division of Executive Operations.
Division of Advisory Committee and Consultant Management.
Office of Translational Sciences.\4\
Office of Biostatistics.
Division of Biometrics I.
Division of Biometrics II.
Division of Biometrics III.
Division of Biometrics IV.
Division of Biometrics V.
Division of Biometrics VI.
Division of Biometrics VII.
Office of Clinical Pharmacology.\1\
Division of Clinical Pharmacology I.
Division of Clinical Pharmacology II.
Division of Clinical Pharmacology III.
Division of Clinical Pharmacology IV.
Division of Clinical Pharmacology V.
Division of Pharmacometrics.
Office of Counter-Terrorism and Emergency Coordinator.
Office of Planning and Informatics.
Office of Planning and Analysis.
Planning and Evaluation Staff.
Analysis Staff.
Office of Business Informatics.
Division of Records Management.
Division of Regulatory Review Support.
Division of Business Analysis and Reporting.
Division of Project Development.
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION.\14\
---------------------------------------------------------------------------
\14\ Mailing address: 5100 Paint Branch Pkwy., College Park, MD
20740-3835.
---------------------------------------------------------------------------
Office of the Center Director.
Senior Science Advisor Staff.
Executive Operations Staff.
International Staff.
Office of Management Systems.
Division of Planning and Financial Resources Management.
Division of Program Support Services.
Office of Food Defense, Communication and Emergency Response.
Division of Education and Communication.
Division of Public Health and Biostatistics.
Office of Food Safety.
Retail Food and Cooperative Programs Support Staff.
Division of Seafood Science and Technology.
Division of Food Processing Science and Technology.
Division of Plant and Dairy Food Safety.
Division of Seafood Safety.
Office of Cosmetics and Colors.
Cosmetic Staff.
Division of Color Certification and Technology.
Office of Regulatory Science.
Division of Analytical Chemistry.
Division of Microbiology.
Division of Bioanalytical Chemistry.
Office of Food Additive Safety.
Senior Science and Policy Staff.
Division of Food Contact Notifications.
Division of Biotechnology and GRAS Notice Review.
Office of Compliance.
Division of Enforcement.
Division of Field Programs and Guidance.
Office of Applied Research and Safety Assessment.
Muirkirk Technical Operations Staff.
Division of Molecular Biology.
Division of Virulence Assessment.
Division of Toxicology.
Office of Regulations, Policy and Social Sciences.
Regulations and Special Government Employees Management Staff.
Division of Social Sciences.
Office of Nutrition, Labeling and Dietary Supplements.
Food Labeling and Standards Staff.
Nutrition Programs Staff.
Infant Formula and Medical Foods Staff.
Division of Dietary Supplement Programs.
CENTER FOR TOBACCO PRODUCTS.\15\
---------------------------------------------------------------------------
\15\ Mailing address: 9200 Corporate Blvd., Rockville, MD 20850.
---------------------------------------------------------------------------
Office of the Center Director.
Office of Management.
Office of Policy.
Office of Regulations.
Office of Science.
NATIONAL CENTER FOR TOXICOLOGY RESEARCH.\16\
---------------------------------------------------------------------------
\16\ Mailing address: 3900 NCTR Rd., Jefferson, AR 72079.
---------------------------------------------------------------------------
Office of the Center Director.
Office of Management.
Office of Executive Programs and Services.
Office of Scientific Coordination.
Office of Research.
Division of Biochemical Toxicology.
Division of Genetic and Reproductive Toxicology.
Genetic Toxicology Laboratory.
Reproductive Toxicology Laboratory.
Division of Personalized Nutrition and Medicine.
Biometry Branch.
Pharmacogenomics Branch.
Division of Microbiology.
Division of Neurotoxicology.
Division of Veterinary Services.
Division of Systems Toxicology.
Office of Regulatory Compliance and Risk Management.
OFFICE OF REGULATORY AFFAIRS.\3\
Equal Employment Opportunity Staff.
Office of Resource Management.\3\
[[Page 16357]]
Division of Planning, Evaluation, and Management.
Division of Human Resource Development.
Division of Management Operations.
Division of Personnel Operations.
Office of Information Technology.
Office of Enforcement.\5\
Division of Compliance Management and Operations.
Division of Compliance Policy.
Division of Compliance Information and Quality Assurance.
Office of Regional Operations.\3\
Division of Federal-State Relations.
Division of Field Science.
Division of Import Operations and Policy.
Division of Field Investigations.
Office of Criminal Investigations.\17\
---------------------------------------------------------------------------
\17\ Mailing address: 7500 Standish Pl., Rockville, MD 20855.
---------------------------------------------------------------------------
Mid-Atlantic Area Office.\3\
Midwest Area Office.\18\
---------------------------------------------------------------------------
\18\ Mailing address: 901 Warrenville Rd., Lisle, IL 60532.
Northeast Area Office.\19\
---------------------------------------------------------------------------
\19\ Mailing address: 10 Exchange Pl., Jersey City, NJ 07302.
Pacific Area Office.\20\
---------------------------------------------------------------------------
\20\ Mailing address: 201 Avenida Fabricante, San Clemente, CA
92672.
Southeast Area Office.\21\
---------------------------------------------------------------------------
\21\ Mailing address: 865 SW 78th Ave., Plantation, FL 33324.
Southwest Area Office.\22\
---------------------------------------------------------------------------
\22\ Mailing address: 5799 Broadmoor St., Mission, KS 66202.
CENTER FOR VETERINARY MEDICINE.\23\
---------------------------------------------------------------------------
\23\ Mailing address: 7519 Standish Pl., Bldg. MPN4, rm. 176,
Rockville, MD 20855.
---------------------------------------------------------------------------
Office of the Center Director.
Office of Management.\24\
---------------------------------------------------------------------------
\24\ Mailing address: 7529 Standish Pl., Bldg. MPN5, rm. 3577,
Rockville, MD 20855.
---------------------------------------------------------------------------
Management Logistics Staff.
Financial Resources Staff.
Human Capital Staff.
Learning Management Staff.
Office of New Animal Drug Evaluation.\25\
---------------------------------------------------------------------------
\25\ Mailing address: 7520 Standish Pl., Bldg. MPN2, rm. 239,
Rockville, MD 20855.
---------------------------------------------------------------------------
Division of Therapeutic Drugs for Non-Food Animals.
Division of Biometrics and Production Drugs.
Division of Therapeutic Drugs for Food Animals.
Division of Human Food Safety.
Division of Manufacturing Technologies.
Division of Scientific Support.
Division of Generic Animal Drugs.
Office of Surveillance and Compliance.\26\
---------------------------------------------------------------------------
\26\ Mailing Address: 7519 Standish Pl., Bldg. MPN5, rm. 300,
Rockville, MD 20855.
---------------------------------------------------------------------------
Division of Surveillance.
Division of Animal Feeds.
Division of Compliance.
Division of Epidemiology.
Office of Research.\27\
---------------------------------------------------------------------------
\27\ Mailing address: 8401 Muirkirk Rd., Bldg. MOD2, rm. G101,
Laurel, MD 20708.
---------------------------------------------------------------------------
Administrative Staff
Division of Residue Chemistry.
Division of Animal Research.
Division of Animal and Food Microbiology.
Office of Minor Use and Minor Species Animal Drug Development.\28\
---------------------------------------------------------------------------
\28\ Mailing address: 7500 Standish Pl., Bldg. MPN2, rm. N378,
Rockville, MD 20855.
---------------------------------------------------------------------------
Sec. 5.1105 Chief Counsel, Food and Drug Administration.
The Office of the Chief Counsel's mailing address is 5600 Fishers
Lane, rm. 6-05, Rockville, MD 20857.\1\
---------------------------------------------------------------------------
\1\ The Office of the Chief Counsel (also known as the Food and
Drug Division, Office of the General Counsel, Department of Health
and Human Services), while administratively within the Office of the
Commissioner, is part of the Office of the General Counsel of the
Department of Health and Human Services.
---------------------------------------------------------------------------
Sec. 5.1110 FDA public information offices.
(a) Division of Dockets Management. The Division of Dockets
Management public room is located in rm. 1061, 5630 Fishers Lane,
Rockville, MD 20852, Telephone: 301-827-6860.
(b) Division of Freedom of Information. The Freedom of Information
public room is located in rm. 6-30, Parklawn Bldg., 5600 Fishers Lane,
Rockville, MD 20857, Telephone: 301-827-6567.
(c) Press Relations Staff. Press offices are located in White Oak
Bldg. 1, 10903 New Hampshire Ave., Silver Spring, MD 20993, Telephone:
301-827-6242; and at 5100 Paint Branch Pkwy., College Park, MD 20740,
Telephone: 301-436-2335.
Dated: March 26, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-7282 Filed 3-31-10; 8:45 am]
BILLING CODE 4160-01-S
